Results 121 to 130 of about 34,512 (245)

The hypermethylation of the O6‐methylguanine‐DNA methyltransferase gene promoter in gliomas—correlation with array comparative genome hybridization results and IDH1 mutation [PDF]

open access: bronze, 2011
Katja Tuononen   +10 more
openalex   +1 more source

Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 11, November 2025.
ABSTRACT Some vascular anomalies, such as hamartomas associated with PTEN hamartoma tumor syndrome (PHTS) and fibroadipose vascular anomaly (FAVA, often due to PI3KCA variants), share similar clinical, radiological, and histopathological presentations that challenge clinicians to provide an accurate diagnosis.
Luciana Daniela Garlisi Torales   +10 more
wiley   +1 more source

Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of theIDH1-R132HMutation in Diffuse Glioma Biopsy Specimens [PDF]

open access: bronze, 2011
Matthias Preusser   +5 more
openalex   +1 more source

Ivosidenib and Azacitidine in IDH1 -Mutated AML

open access: yesNew England Journal of Medicine, 2022
Goodman, Aaron M   +2 more
openaire   +6 more sources

Magnetic Resonance Spectroscopy of 2‐Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas

open access: yesNMR in Biomedicine, Volume 38, Issue 11, November 2025.
MRS of 2‐hydroxyglutarate (2HG) and glycine in 19 patients with brainstem tumors is reported. TE 97ms PRESS was obtained at 3T and LCModel was used for spectral fitting. Tumors with elevated 2HG and undetectable 2HG were clearly distinguishable. Tumors with elevated glycine showed rapid progression.
Vivek Tiwari   +18 more
wiley   +1 more source

Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3

open access: yesBrain Pathology, Volume 35, Issue 6, November 2025.
The Hippo pathway transcription factor TEAD3 represents an independent prognostic biomarker of tumor recurrence and a potential therapeutic vulnerability through its regulation of cholesterol metabolism in glioma. Abstract Glioblastomas represent the most common and lethal primary brain tumors in the world.
Konstantin Masliantsev   +10 more
wiley   +1 more source

Diagnosis and treatment of occipital brain lesions in children

open access: yesDevelopmental Medicine &Child Neurology, Volume 67, Issue 11, Page 1409-1420, November 2025.
Occipital brain lesions in children represent a diagnostic challenge due to the large spectrum of etiologies and overlapping clinical features. This review analyses common and less common causes of occipital brain lesions in children, including malformative, vascular, genetic/metabolic, infectious, inflammatory, and neoplastic conditions.
Luca Bartolini   +4 more
wiley   +1 more source

IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom [PDF]

open access: bronze, 2012
Florian Stockhammer   +6 more
openalex   +1 more source

Constructing a Model Using Clock‐Related lncRNAs for Predicting the Tumor Microenvironment of Gliomas

open access: yesBrain and Behavior, Volume 15, Issue 10, October 2025.
Step 1: Identify hub clock‐related genes through differential expression analysis, univariate Cox analysis, and LASSO‐Cox regression; Step 2: Identify and screen hub clock‐related lncRNAs using correlation analysis and LASSO‐Cox regression; Step 3: Validate the expression differences of the selected lncRNAs in cell experiments using qPCR.
Mingjie Gong   +5 more
wiley   +1 more source

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function [PDF]

open access: gold, 2012
Masato Sasaki   +19 more
openalex   +1 more source

Home - About - Disclaimer - Privacy